SINGAPORE: The first participants of an early-stage COVID-19 vaccine trial have been given the potential vaccine, said Arcturus Therapeutics ...
SINGAPORE: The first participants of an early-stage COVID-19 vaccine trial have been given the potential vaccine, said Arcturus Therapeutics Holdings on Tuesday .
The potential vaccine is jointly developed by Arcturus and Singapore's Duke-NUS Medical School. Results from the trial are expected in the fourth quarter of this year.The company is among several drugmakers racing to develop a safe and effective vaccine for the new coronavirus that has killed more than 735,000 people globally.
In April, Arcturus said preclinical data testing of its experimental vaccine, known as ARCT-021, showed the vaccine candidate could trigger an immune response to the virus.
ARCT-021, like Moderna's COVID-19 vaccine candidate, uses mRNA, or messenger RNA, to inoculate against the coronavirus.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sinovac launches late-stage trial for potential COVID-19 vaccine in IndonesiaJAKARTA: China's Sinovac Biotech launched on Tuesday (Aug 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a ...
Read more »
Sinovac launches late-stage trial for potential Covid-19 vaccine in IndonesiaJAKARTA/BEIJING (REUTERS) - China's Sinovac Biotech launched on Tuesday(Aug 11) a late-stage human trial involving as many as 1,620 patients in Indonesia for a Covid-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.. Read more at straitstimes.com.
Read more »
Johnson & Johnson eyes 1 billion doses of potential Covid-19 shot in 2021, weighs challenge trialsBRUSSELS (REUTERS) - Johnson & Johnson could produce 1 billion doses of its potential Covid-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the novel coronavirus if there are not enough patients for final trials, a company executive said.. Read more at straitstimes.com.
Read more »
J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trialsBRUSSELS: Johnson & Johnson could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider ...
Read more »
China's Sinopharm starts Phase III trial of COVID-19 vaccine in BahrainChinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Bahrain, after launching similar ...
Read more »